KR950008494A - 나프톡사진 - Google Patents

나프톡사진 Download PDF

Info

Publication number
KR950008494A
KR950008494A KR1019940021968A KR19940021968A KR950008494A KR 950008494 A KR950008494 A KR 950008494A KR 1019940021968 A KR1019940021968 A KR 1019940021968A KR 19940021968 A KR19940021968 A KR 19940021968A KR 950008494 A KR950008494 A KR 950008494A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
compound
cycloalkyl
alkenyl
Prior art date
Application number
KR1019940021968A
Other languages
English (en)
Inventor
노줄락 요하킴
Original Assignee
피터 라스 한스,루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피터 라스 한스,루돌프 하우스, 산도즈 리미티드 filed Critical 피터 라스 한스,루돌프 하우스
Publication of KR950008494A publication Critical patent/KR950008494A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38—[b, e]-condensed with two six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

본 발명은 하기 일반식(I)의 화합물 및 그 제조방법에 관한 것이다.
상기식에서, R1, R2및 R3는 제1항에서 정의된 바와 동일하다. 일반식(I)의 화합물은 약물로서 사용될 수 있다.

Description

나프톡사진
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 유리 염기 또는 산 부가염 형태의 하기 일반식(I)의 화합물 :
    상기식에서, R1은 (C1-4)알킬, 이중결합이 질소원자에 대한 α-위치에 존재하지 않는 (C3-6)알케닐 또는 (C3-7)시클로알킬 (C1-2)알킬이고, R2는 (C1-4)알콕시, (C2-6)알케닐옥시 또는 (C3-7)시클로알킬 (C1-2)알콜시이고, R3는 (C1-4)알킬카르보닐, (C1-4)알킬, α-히드록시 (C1-4)알킬, (C2-5)알케닐, (C1-4)알콕시 (C1-4)알킬 또는 (C3-7)시클로알킬이다.
  2. 유리 염기 또는 산 부가염 형태의 (-)-(1'R, 4aR, 10aR)-3,4,4a,5,10,10a-헥사히드로-9-(1'-메톡시에틸)-6-메톡시-4-메틸-2H-나프트[2,3-b]-1,4-옥사진.
  3. 유리 염기 또는 생리적으로 허용가능한 산 부가염 형태의, 제1항 또는 제2항의 화합물을 약제학적 담체 또는 희석제와 함께 포함하는 약제학적 조성물.
  4. (a)하기 일반식(II)의 화합물을9-위치에서 아실화시켜 하기 일반식(Ib)의 화합물을 제조하거나, (b)하기 일반식(II)의 화합물을9-위치에서 알킬화시켜 하기 일반식(Ib)의 화합물을 제조하고 바람직하게는, 이렇게하여 수득된 하기 일반식(I)의 화합물을 그들의 산 부가염으로 전환시킴으로써, 제1항에서 정의된 하기 일반식(I)의 화합물을 제조하는 방법.
    상기식에서, R1, R2및 R3는 제1항에서 정의된 바와 동일하고, Ra 3은 (C1-4)알킬, 카르보닐이고 Rb 3는 (C1-4)일킬 α-히드록시(C1-4)알킬, (C2-5)알케닐 (C1-4)알콕시 (C1-4)알킬 또는 (C3-7)시클로알킬이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940021968A 1993-09-03 1994-09-01 나프톡사진 KR950008494A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4329776.5 1993-09-03
DE4329776A DE4329776A1 (de) 1993-09-03 1993-09-03 Naphthoxazine, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
KR950008494A true KR950008494A (ko) 1995-04-17

Family

ID=6496759

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940021968A KR950008494A (ko) 1993-09-03 1994-09-01 나프톡사진

Country Status (16)

Country Link
EP (1) EP0641787A1 (ko)
JP (1) JPH07165736A (ko)
KR (1) KR950008494A (ko)
CN (1) CN1105998A (ko)
AU (1) AU7164394A (ko)
CA (1) CA2117656A1 (ko)
CZ (1) CZ211094A3 (ko)
DE (1) DE4329776A1 (ko)
FI (1) FI944012A (ko)
HU (1) HUT71117A (ko)
IL (1) IL110833A0 (ko)
NO (1) NO943230L (ko)
PL (1) PL304878A1 (ko)
RU (1) RU94032148A (ko)
SK (1) SK104894A3 (ko)
ZA (1) ZA946769B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
CA2740873C (en) 2008-10-17 2019-09-10 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193979B (en) * 1984-06-12 1987-12-28 Sandoz Ag Process for producing naphtoxazine derivatives and pharmaceutical compositions containing them
HU214591B (hu) * 1989-12-14 1998-04-28 Novartis Ag. Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására

Also Published As

Publication number Publication date
JPH07165736A (ja) 1995-06-27
FI944012A0 (fi) 1994-09-01
HUT71117A (en) 1995-11-28
FI944012A (fi) 1995-03-04
RU94032148A (ru) 1996-07-10
NO943230L (no) 1995-03-06
CN1105998A (zh) 1995-08-02
CZ211094A3 (en) 1995-03-15
AU7164394A (en) 1995-03-16
ZA946769B (en) 1996-03-04
SK104894A3 (en) 1995-05-10
NO943230D0 (no) 1994-09-01
HU9402534D0 (en) 1994-10-28
EP0641787A1 (en) 1995-03-08
IL110833A0 (en) 1994-11-28
PL304878A1 (en) 1995-03-06
DE4329776A1 (de) 1995-03-09
CA2117656A1 (en) 1995-03-04

Similar Documents

Publication Publication Date Title
KR830004202A (ko) 항우울제로서 시스-4-페닐-1,2,3,4-테트라하이드로-1-나프탈렌아민 유도체의 제조방법
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
RU2695274C3 (ru) Новые композиции и способы их стабилизации
KR880012551A (ko) 피페리딘 아편양 길항체
ATE105556T1 (de) Benzopyranverbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
RU97100172A (ru) Лиганды серотонинового 5-нт1а и допаминового d2 рецепторов
EP0257741A3 (en) Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
RU2218334C2 (ru) Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцин-10-олы и фармацевтическая композиция на их основе
KR950008494A (ko) 나프톡사진
KR900018048A (ko) 환 치환된 2-아미노-1,2,3,4-테트라하이드로나프탈렌
KR880011112A (ko) 벤즈아제핀 설폰아미드 화합물
KR870001214A (ko) 4,7-디히드로티에노[2,3-b]피리딘 유도체의 제조방법
JPS57192339A (en) Isoprenylamine derivative
KR920703563A (ko) 6-(하이드로나프틸-1-에틸)-4-히드록시-3,4,5,6-테트라하이드로-2h-피란-2온과 이의 해당 히드록시산
IE863374L (en) Indoles.
KR890002168A (ko) 디하이드로-1,4-옥사지노[2,3-c]퀴놀린, 그의 제조방법 및 중간생성물 및 약제로서의 용도
EA200200263A3 (ru) Новые производные инденоиндолона, способ их получения и содержащие их фармацевтические композиции
IE37140L (en) 1, 3-diamino-2-propanols
KR850000415A (ko) 퀴나졸리논 유도체의 제조방법
KR910002855A (ko) 5 6-디하이드로[1H-인돌로[3,2,-c]퀴놀린-6,4-피페리딘] 및 관련화합물, 이의 제조방법 및 약제로서의 용도
KR910004627A (ko) 피리도[3,4-b][1,4]벤즈옥사제핀, 이의 제조방법 및 약제로서의 이의 용도
KR920002594A (ko) 5-이소티아졸아민 유도체
KR900011757A (ko) 피리디늄 니트레이트, 그의 제조방법 및 용도
KR900011769A (ko) 신규 벤조[1,8] 나프티리딘 유도체 및 그의 제법
KR880005128A (ko) 이미다조[4,5-b]피리딘-2-온 유도체, 그의 제법 및 치료에의 응용

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid